News

RCP Advisors Achieves Major Milestone with Fund Close at $1.26B

RCP Advisors Achieves Major Milestone with Fund Close at $1.26B

RCP Advisors Celebrates Successful Fund Closure

DALLAS, significant news has emerged as P10, Inc. (NYSE: PX), a prominent name in private markets solutions, teams up with RCP Advisors, known for its expertise in small buyout strategies. This partnership has heralded the final closure of the RCP Secondary Opportunity Fund V, LP, commonly referred to as RCP SOF V. The Fund, boasting $1.26 billion in capital commitments, has successfully exceeded its initial $1 billion target, illustrating the strong interest and confidence of the investor base.

A Wide Array of Support from Investors

The success of RCP SOF V is attributed to a diverse mix of limited partners. This impressive group includes both new and existing investors such as high net worth individuals, pension funds, endowments, and insurance companies, all coming together to support the Fund's mission.

Luke Sarsfield, the Chairman and CEO of P10, expressed commendation for RCP Advisors, stating that the successful closure of RCP SOF V is a testament to the trust investors place in the firm’s investment approach amidst rising demand for small buyout funds in North America. Sarsfield emphasized the commitment to provide exceptional access to unique investment opportunities in the lower middle market. He acknowledged the invaluable contributions of the RCP team, highlighting their extensive expertise that bolsters the entire P10 platform.

Investment Strategies of RCP SOF V

RCP SOF V continues the investment tradition established by its predecessor secondary funds, focusing primarily on secondary market transactions. These may include purchases linked to both limited partner (LP) and general partner (GP)-led transactions targeting private equity funds. These funds typically focus on leveraged buyouts, growth, and restructuring initiatives.

Jon Madorsky, the Managing Partner and Co-Portfolio Manager at RCP, noted the favorable reactions from the market towards RCP SOF V, indicating that their unwavering commitment to investing in small buyout funds resonates with investors. His sentiments were echoed by fellow Co-Portfolio Manager, Raj Patel, who underscored the reasons behind raising an oversubscribed secondary capital pool in record time. They attribute this success to a robust track record, unique focus, and appealing secondary buying opportunities, paving the way for a fruitful investment phase for RCP SOF V.

About P10 and RCP Advisors

P10 (NYSE: PX) stands out as a leading provider of private market solutions, managing over $40 billion in assets as of mid-2025. Their investment strategies span Private Equity, Private Credit, and Venture Capital, focusing on middle and lower-middle market ventures that are often less accessible. The products offered by P10 are designed to deliver compelling, risk-adjusted returns for a global investor base.

RCP Advisors, established in 2001, and a proud subsidiary of P10, Inc. (NYSE: PX), serves as a pivotal player in the private equity landscape. The firm specializes in granting access to North American small buyout fund managers through various fund types, including primary, secondary, and co-investment funds. With a significant footprint, RCP Advisors boasts 58 funds, over 550 partnership investments, 56 dedicated professionals, and more than 2,700 global limited partners as of mid-2025.

Frequently Asked Questions

What is RCP Secondary Opportunity Fund V?

RCP Secondary Opportunity Fund V, LP, is a fund managed by RCP Advisors, focusing on private equity opportunities primarily through secondary market transactions.

How much capital has RCP SOF V raised?

The fund successfully raised $1.26 billion in capital commitments, surpassing its initial target of $1 billion.

Who are the investors in RCP SOF V?

The fund has a diverse group of limited partners, including high net worth individuals, pension funds, endowments, and insurance companies.

What types of investments does RCP SOF V target?

RCP SOF V primarily targets investments in private equity funds focusing on leveraged buyouts, growth, and restructuring transactions.

What is P10's role in RCP Advisors?

P10, Inc. (NYSE: PX) is the parent company of RCP Advisors, providing private market solutions and managing a significant amount of assets across various investment strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 73

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
Banco Macro S.A. Plans $160B Share Buyback Initiative

Updated Category News Views 24

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Continue Reading
Enertech's New Moves Aim to Make Geothermal Mainstream

Updated Category News Views 74

Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...

Continue Reading
Agrochemicals: Combining Tradition and Innovation

Updated Category News Views 69

The Evolving World of Agrochemicals You know, the agrochemical market isn't just about fertilizers and pesticides anymore. It's evolving into a high-stakes game of innovation, resistance management, and cutting-edge tech. This whole sector's forecast to explode to a whopping US$ 387.7 billion by 2031. That's no small potatoes. Driving Forces: Pests, Drones, and Regulatory...

Continue Reading
Insurify's AI Gateway: A New Era in Insurance Shopping

Updated Category News Views 66

Insurify's Game-Changing AI Agent Gateway In the insurance world, Insurify's latest move feels like a bull charging through a ticker tape parade. This Cambridge-based pioneer unveiled its AI Agent Gateway, aiming to put consumers back in the driver's seat. By connecting digital assistant agents to its platform, Insurify's making insurance shopping a bit less like pulling...

Continue Reading
Royce Micro-Cap Trust: Navigating Small-Cap Waves

Updated Category News Views 42

Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 99

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 68

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 111

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading
Royce Small-Cap Trust Shows Resilience Amid Volatility

Updated Category News Views 95

A Closer Look at Royce's Latest Moves Royce Small-Cap Trust (NYSE: RVT), the venerable old timer in the small-cap fund world, has been trucking along the market's bumpy byways since forever ago. With over 50 years of small- and micro-cap investment experience under its belt, you'd think it might have seen everything by now. But in the volatile world of small caps,...

Continue Reading

Top 5 Most Recently Viewed Articles

Gen Z Hacks Loyalty Programs with AI Power Play

Updated Category News Views 15

Gen Z Leads the Charge in AI-Driven Loyalty The times, they are a-changin', and loyalty programs aren't immune. Hopping on the AI bandwagon, 64% of Gen Z in the UK and 55% in the US are getting more bang for their buck, utilizing AI to optimize their participation and rake in rewards. According to Comarch's latest findings, these young savants aren't just after luxury...

Continue Reading
SendCutSend Triumphs in American Business Awards with Gold

Updated Category News Views 302

SendCutSend Wins Gold Stevie Award at American Business Awards SendCutSend has received a significant honor by winning a coveted Gold Stevie Award in the Manufacturing category during the American Business Awards. This prestigious award program recognizes excellence in various sectors across the country. The awards attracted over 3,600 submissions from multiple...

Continue Reading
Explore the Glow Up Golden Calendar for 2026 Launch

Updated Category News Views 393

Glow Up Golden 2026 Calendar Unveiled at Pearl River Mart -Inspired by ancient Chinese timing to support modern decision-making- In a vibrant new partnership, Julie Huang, renowned writer and Chinese metaphysics practitioner, is set to launch the Glow Up Golden 2026 Calendar at Pearl River Mart. This culturally enriching calendar draws on classical Chinese wisdom, making...

Continue Reading
Luminar Technologies Faces Lawsuit: Investors Take Action

Updated Category News Views 278

Investors Encouraged to Act on Luminar Technologies Lawsuit The focus is now on Luminar Technologies, Inc. (NASDAQ: LAZR) as the opportunity arises for investors to join a significant class action lawsuit. This comes in light of recent allegations of securities fraud within the company. Investors who purchased Luminar securities within the specified time frame are urged...

Continue Reading
Understanding Recent Trends in Catalyst Pharmaceuticals' Short Interest

Updated Category News Views 176

Recent Trends in Catalyst Pharmaceuticals' Short Interest Catalyst Pharmaceuticals (CPRX) has seen a notable increase in its short percent of float, jumping by 5.8% since the last report. The latest figures indicate that about 8.17 million shares are currently sold short, representing 8.57% of all shares available for trading. Based on trading volume, it would take...

Continue Reading